Funding
← Back to your selection

Elevage Medical Technologies

Activity from announced rounds

Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026

Elevage Medical Technologies is the investment organization whose official news identifies Nuclera, Imperative Care and Elucid.

Recorded funding activity

Elucid analyzes CT angiography to characterize arterial plaque. Nervonik develops peripheral nerve stimulation, while Imperative Care develops treatments for thromboembolic disease. These company records connect the organization to different diagnostic and treatment technologies.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$207.5M
3 disclosed · full round size, not this investor’s share

By stage

Growth1
Series B1
Series C+1

By primary sector

Healthtech3

By country

United States3

Rounds

3 in this selection
Elucid

Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.

$55MSeries D
Participant
Nervonik

Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions

$52.5MSeries B
Role not disclosed
Imperative Care

Develops treatments for patients suffering from thromboembolic disease

$100MGrowth
Role not disclosed